Clinical diagnostic strategies mainly focus on the detection and quantification of biotargets (e.g., lipids, nucleic acids, and proteins) from circulation or other bodily fluids [1]. Developing reliable, inexpensive, and robust diagnostic assays at the point-of-care has revitalized existing platforms by paving the way for more individualized monitoring and increased accessibility to diagnostics in remote and resource-limited settings. Despite the utility and broad audience of DNA microarray-based diagnostic technologies [2], developing protein arrays has still obstacles due to their fragile nature, limiting their three-dimensional (3-D) structure and functionality outside their native milieu. The need for novel analytical concepts is hence inevitable. In the next sections, we provide multiple liposome and SLB-based systems that are seeking to address these challenges in the realm of diagnostics.
CITATION STYLE
Öztürk Öncel, M. Ö., Garipcan, B., & Inci, F. (2019). Biomedical Applications: Liposomes and Supported Lipid Bilayers for Diagnostics, Theranostics, Imaging, Vaccine Formulation, and Tissue Engineering. In Biomimetic Lipid Membranes: Fundamentals, Applications, and Commercialization (pp. 193–212). Springer International Publishing. https://doi.org/10.1007/978-3-030-11596-8_8
Mendeley helps you to discover research relevant for your work.